CLINICAL_TRIALS
trial_result
· 2023-12-20
Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of BIIB093 in Participants With Brain Contusion [Phase 2]
Summary
A Phase 2 trial evaluating BIIB093 for brain contusion was terminated, and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Remedy Pharmaceuticals, Inc. | Conditions: Brain Contusion | Phase 2 | Status: TERMINATED | Results posted: 2023-12-20